Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

fenretinide

An orally-active synthetic phenylretinamide analogue of retinol (vitamin A) with potential antineoplastic and chemopreventive activities. Fenretinide binds to and activates retinoic acid receptors (RARs), thereby inducing cell differentiation and apoptosis in some tumor cell types. This agent also inhibits tumor growth by modulating angiogenesis-associated growth factors and their receptors and exhibits retinoid receptor-independent apoptotic properties.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:fenretinimide
Abbreviation:4-HPR
Code name:McN-R-1967
Chemical structure:4-(all-trans-retino-yl)aminophenol
4-hydroxyphenylretinamide
All-trans-4'-hydroxyretinanilide
all-trans-N-(4-hydroxyphenyl)retinamide
all-trans-N-4'-hydroxyretinanilide
N-(4-hydroxyphenyl)retinamide
IND number:40294
NSC code:374551
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search